Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MENTAL DISEASE THERAPEUTIC AGENT
Document Type and Number:
Japanese Patent JP2013023459
Kind Code:
A
Abstract:

To provide a therapeutic agent of cognitive dysfunction of schizophrenia, mental disease related to schizophrenia, and attention deficit and attention deficit hyperactivity disorder (ADHD).

This therapeutic agent of mental disease related to an executive function is obtained by combining blonanserin or its salt allowed pharmacologically, and tandspirone or its salt allowed pharmacologically.


More Like This:
JP2021535160Cyclohexane derivative salt
WO/2001/019821BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D¿4? ANTAGONISTS
JP3103380[Title of the Invention] A novel pyridonecarboxylic acid derivative or a salt thereof, and an antibacterial agent containing the substance as an active ingredient.
Inventors:
IKEDA KAZUHITO
BABA SATOKO
Application Number:
JP2011158149A
Publication Date:
February 04, 2013
Filing Date:
July 19, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DAINIPPON SUMITOMO PHARMA CO
International Classes:
A61K31/496; A61K31/506; A61P25/00; A61P25/18; A61P25/28; A61P43/00
Attorney, Agent or Firm:
Yobe
Mayumi Matsuo
Horikawa Tamaki
Yuki Ito



 
Previous Patent: METHOD FOR PRODUCING α,β-UNSATURATED CARBOXYLIC ACID

Next Patent: METHOD OF PRODUCING REACTION PRODUCT OF SUBSTRATE AND HYDROGEN